Article Versions Notes

Arrué L, Cigna-Méndez A, Barbosa T, Borrego-Muñoz P, Struve-Villalobos S, Oviedo V, Martínez-García C, Sepúlveda-Lara A, Millán N, Márquez Montesinos JCE, et al. New Drug Design Avenues Targeting Alzheimer’s Disease by Pharmacoinformatics-Aided Tools. Pharmaceutics. 2022; 14(9):1914. https://doi.org/10.3390/pharmaceutics14091914

Arrué, Lily, Alexandra Cigna-Méndez, Tábata Barbosa, Paola Borrego-Muñoz, Silvia Struve-Villalobos, Victoria Oviedo, Claudia Martínez-García, Alexis Sepúlveda-Lara, Natalia Millán, José C. E. Márquez Montesinos, and et al. 2022. "New Drug Design Avenues Targeting Alzheimer’s Disease by Pharmacoinformatics-Aided Tools" Pharmaceutics 14, no. 9: 1914. https://doi.org/10.3390/pharmaceutics14091914

Arrué, L., Cigna-Méndez, A., Barbosa, T., Borrego-Muñoz, P., Struve-Villalobos, S., Oviedo, V., Martínez-García, C., Sepúlveda-Lara, A., Millán, N., Márquez Montesinos, J. C. E., Muñoz, J., Santana, P. A., Peña-Varas, C., Barreto, G. E., González, J., & Ramírez, D. (2022). New Drug Design Avenues Targeting Alzheimer’s Disease by Pharmacoinformatics-Aided Tools. Pharmaceutics, 14(9), 1914. https://doi.org/10.3390/pharmaceutics14091914